Clinical trial Recruiting at 1 site Interventional Ages 65 to 80

Etomidate–propofol mixture versus propofol for anesthesia in older adults having abdominal surgery

Official title: Safety of Etomidate-propofol Mixture vs. Propofol for Total Intravenous Anesthesia in Elderly Patients Undergoing Abdominal Surgery - A Randomized, Double-blind, Controlled Study

Run by Tongji Hospital · NCT07019246 · Data updated 2026-11-12

This trial will test whether mixing etomidate with propofol is safer than propofol alone for total intravenous anesthesia in older adults undergoing abdominal surgery.

Quick facts

Study typeInterventional
Ages65 Years to 80 Years
SexAll
Enrollment166 (estimated)
SponsorTongji Hospital
Academic / other
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedMay 30, 2026
Study endsJune 5, 2026
Registry record updatedJune 17, 2025
Trial IDNCT07019246 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are older adults scheduled for elective abdominal surgery lasting 1–4 hours who are ASA physical status I–III with BMI 18–28.

Probably not a fit

Patients with recent sepsis or multiple organ failure, severe liver or kidney dysfunction, recent stroke or major cardiac events, uncontrolled diabetes with complications, or those undergoing liver, kidney, or adrenal surgery are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will compare a mixture of etomidate and propofol to propofol alone for total intravenous anesthesia in older adults having elective abdominal operations. Eligible participants (ASA I–III, BMI 18–28) who expect 1–4 hours of anesthesia will receive one of the two anesthesia regimens during surgery and will be monitored closely. The study will record intraoperative hypotension, perioperative cardiovascular events, and measures of adrenal cortical function in the 48 hours after surgery. Safety outcomes, awakening times, and postoperative complications will be compared between the two groups.

Why it matters

Potential benefit: If successful, this approach could lower the rate of intraoperative hypotension and reduce perioperative cardiovascular complications while maintaining rapid recovery.

How similar studies have gone: Prior studies show etomidate preserves blood pressure better than propofol but causes temporary adrenal suppression, and combining the drugs is a plausible but not yet well-established strategy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ASA Ⅰ\~Ⅲ;
* BMI was 18-28 kg/m2;
* For elective abdominal surgery under intravenous general anesthesia;
* The expected duration of anesthesia was 1 to 4 hours.

Exclusion Criteria:

* Septic shock and multiple organ failure diagnosed within 14 days;
* Hyperkalemia (serum potassium \>5.5mmol/L) within 48 hours;
* Stroke or transient ischemic attack within 3 months;
* Patients with unstable angina pectoris or myocardial infarction within 3 months; Arrhythmia requiring treatment was not treated or treatment did not meet expectations;
* Patients with preoperative diagnosed diabetes mellitus and uncontrolled blood glucose; Diabetic complications were diagnosed before surgery, including diabetic ketoacidosis, hyperosmolar coma, diabetes-related infection, diabetic nephropathy, retinopathy, diabetic cardiomyopathy, diabetic neuropathy, diabetic foot, etc.
* Severe liver and renal dysfunction;
* Liver surgery, renal surgery, adrenal surgery, day surgery;
* Resting blood pressure ≥180/110 mmHg (2020 ISH hypertension guideline ≥ grade 3 hypertension); Or systolic blood pressure \<90mmHg or mean blood pressure \<65mmHg.
* Taking corticosteroids or other immunosuppressants for more than 10 days within 6 months or having a history of adrenal cortex suppression or immune system diseases;

Where it's running

  • Tongji hospital
    Wuhan, Hubei, China
    Recruiting

Study contacts

  • Principal investigator: Shiyong Li — Department of Anesthesiology of Tongji Hospital
  • Study coordinator: Shiyong Li
  • Email: shiyongli@hust.edu.cn
  • Phone: 02783665480

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.